Eventbrite s fee is nonrefundable.
Event description
The first of its kind in Australia, the Australian Bragg Centre will provide next-generation cancer treatment to children and adults. About this Event
This IHEA Professional Development event will be delivered by two leading speakers in the field – Mr Stephen Spotts, Protom CEO, and Dr Ben Saxon, WCHN Head of Paediatric Haematology and Oncology.
Speakers
Mr Stephen Spotts, CEO of ProTom will speak about the ProTom technology and his commitment to increasing access to proton therapy technology. Like many families, his family has been affected by cancer. Mr. Spotts believes proton therapy should be available to all patients who would benefit from it. Mr. Spotts will also give some insights into the challenges of constructing a building to accommodate the technology.